Riebman Jerome
Known title: CHIEF MEDICAL OFFICERCIK: 0001825821
Associated companies
Transaction History
| ELUT | ▼ Sell | Tax Withholding | 5,104 | $37K | 9/8/2022 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 14,758 | — | 9/8/2022 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 782 | $0 | 3/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Elutia Secures $8M from Boston Scientific, Funds Through 2029
Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.
Elutia Secures $8M from Boston Scientific, Funds Through 2029. Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.